Clinical Trial Update: Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial exploring unsupervised machine learning to cluster septic patients to determine optimal treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Dascena | Conditions: Sepsis, Severe Sepsis | Phase 2 | Status: UNKNOWN